Ramsay Health Care

Ramsay Health Care is a leading global private healthcare provider, founded in 1964 by Paul Ramsay and headquartered in Sydney, Australia. The company operates over 460 facilities, including approximately 235 hospitals and day surgery centers, across ten countries, with a strong presence in Australia, France, the United Kingdom, and Sweden. It offers a range of healthcare services, including day surgery procedures, complex surgeries, psychiatric care, and rehabilitation services. Ramsay Health Care is recognized as the largest private hospital group in Australia, France, and Sweden, and ranks fifth in the UK. The company generates a significant portion of its earnings from Australia and France, with approximately 60% of consolidated earnings coming from Australia and around 30% from France.

Craig McNally

Managing Director and CEO

3 past transactions

Elysium Healthcare

Acquisition in 2021
Elysium Healthcare is a provider of specialized mental health services in the United Kingdom, focusing on acute mental illness, personality disorders, and eating disorders. Founded in December 2016, the company operates across 22 sites, which include facilities for secure and rehabilitation care. Elysium offers a range of services, including psychiatric intensive care units, disability care, and neurological healthcare, as well as dedicated private health services for children and adolescents. The organization aims to deliver comprehensive and compassionate care to individuals with diverse mental health needs.

Spire Healthcare Group

Acquisition in 2021
Spire Healthcare Group is an independent hospital group based in London, United Kingdom, specializing in private healthcare services. Established in 2007, it operates 40 private hospitals and eight clinics, offering a range of services including inpatient and outpatient care, diagnostics, and day cases. The group is particularly known for its high volume of knee and hip operations, making it a key player in the UK's private healthcare sector. Spire Healthcare is committed to delivering successful clinical outcomes, which has earned it recognition among patients, consultants, and private medical insurance providers. The company provides care through various channels, including private medical insurance, self-pay options, and partnerships with the National Health Service, thereby ensuring diversified access to the growing opportunities within the UK healthcare market.

Harrison.ai

Series A in 2019
Harrison.ai is a clinician-led healthcare AI company founded in 2018 and headquartered in Barongarook, Victoria, Australia. The company focuses on using deep learning technology to enhance the success rates of in vitro fertilization (IVF) for patients. By developing customized AI-enabled tools that seamlessly integrate into existing clinical workflows, Harrison.ai aims to empower healthcare providers and improve patient outcomes. Its IVY deep learning model uniquely analyzes comprehensive five-day video feeds from embryo scopes, surpassing the capabilities of traditional AI tools that rely on static images. Harrison.ai combines deep learning expertise with clinical experience to create innovative healthcare solutions, striving to make healthcare products and services more efficient and affordable for medical institutions and patients alike.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.